1016 related articles for article (PubMed ID: 30639476)
1. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
2. SENP2 alleviates CCl
Bu FT; Chen Y; Yu HX; Chen X; Yang Y; Pan XY; Wang Q; Wu YT; Huang C; Meng XM; Li J
Toxicol Lett; 2018 Jun; 289():86-98. PubMed ID: 29535048
[TBL] [Abstract][Full Text] [Related]
3. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
5. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Perumal N; Perumal M; Halagowder D; Sivasithamparam N
Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
[TBL] [Abstract][Full Text] [Related]
6. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.
Lee EH; Park KI; Kim KY; Lee JH; Jang EJ; Ku SK; Kim SC; Suk HY; Park JY; Baek SY; Kim YW
Phytomedicine; 2019 Sep; 62():152780. PubMed ID: 31121384
[TBL] [Abstract][Full Text] [Related]
7. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway.
Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J
Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796
[TBL] [Abstract][Full Text] [Related]
8. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
Konishi T; Schuster RM; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
[TBL] [Abstract][Full Text] [Related]
9. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
Wu SM; Li TH; Yun H; Ai HW; Zhang KH
Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
[TBL] [Abstract][Full Text] [Related]
10. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.
Yang Y; Chen XX; Li WX; Wu XQ; Huang C; Xie J; Zhao YX; Meng XM; Li J
J Cell Mol Med; 2017 Oct; 21(10):2317-2328. PubMed ID: 28332284
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation.
Li L; Zhou J; Li Q; Xu J; Qi J; Bian H
Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470
[TBL] [Abstract][Full Text] [Related]
12. CD73 regulates hepatic stellate cells activation and proliferation through Wnt/β-catenin signaling pathway.
Jia WQ; Zhou TC; Dai JW; Liu ZN; Zhang YF; Zang DD; Lv XW
Eur J Pharmacol; 2021 Jan; 890():173667. PubMed ID: 33121948
[TBL] [Abstract][Full Text] [Related]
13. PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway.
Chen Y; Chen X; Ji YR; Zhu S; Bu FT; Du XS; Meng XM; Huang C; Li J
J Cell Mol Med; 2020 Jul; 24(13):7405-7416. PubMed ID: 32463161
[TBL] [Abstract][Full Text] [Related]
14. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
15. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
[TBL] [Abstract][Full Text] [Related]
16. TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cells.
Xu DD; Li XF; Li YH; Liu YH; Huang C; Meng XM; Li J
Biochem Biophys Res Commun; 2018 Mar; 498(1):199-206. PubMed ID: 29196266
[TBL] [Abstract][Full Text] [Related]
17. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
[TBL] [Abstract][Full Text] [Related]
18. CTRP3 attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway.
Cheng C; Yu S; Kong R; Yuan Q; Ma Y; Yang W; Cao G; Xie L
Biomed Pharmacother; 2017 May; 89():1387-1391. PubMed ID: 28320106
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R.
Yang JJ; Liu LP; Tao H; Hu W; Shi P; Deng ZY; Li J
Toxicology; 2016 Jun; 359-360():39-46. PubMed ID: 27350269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
